{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:59:22Z","timestamp":1789185562179,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ajem.2017.11.037","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T02:30:18Z","timestamp":1511231418000},"page":"1312-1314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Experience with dalbavancin for cellulitis in the emergency department and emergency observation unit"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-3435","authenticated-orcid":false,"given":"Christian","family":"Koziatek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Caspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajem.2017.11.037_bb0005","doi-asserted-by":"crossref","first-page":"A240","DOI":"10.1016\/j.jval.2012.03.1298","article-title":"Economic burden of hospitalization with antibiotic treatment for ABSSSI in the United States: an analysis of the premier hospital database","volume":"15","author":"La Pensee","year":"2012","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.ajem.2017.11.037_bb0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1155\/2008\/846453","article-title":"Bacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis, treatment and site of care","volume":"19","author":"Ki","year":"2008","journal-title":"Can J Infect Dis Med Microbiol = J Can des Mal Infect la Microbiol medicale"},{"issue":"2","key":"10.1016\/j.ajem.2017.11.037_bb0015","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ajem.2017.11.037_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clinthera.2015.11.014","article-title":"Economic impact of oritavancin for the treatment of acute bacterial skin and skin structure infections in the emergency department or observation setting: cost savings associated with avoidable hospitalizations","volume":"38","author":"Lodise","year":"2016","journal-title":"Clin Ther"},{"issue":"12","key":"10.1016\/j.ajem.2017.11.037_bb0025","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3111\/13696998.2015.1078339","article-title":"Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting","volume":"18","author":"Ektare","year":"2015","journal-title":"J Med Econ"},{"key":"10.1016\/j.ajem.2017.11.037_bb0030","first-page":"1","article-title":"Dalbavancin as a cost effective antibiotic","author":"Nair","year":"2017","journal-title":"Infect Dis (Auckl)"},{"key":"10.1016\/j.ajem.2017.11.037_bb0035","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2147\/TCRM.S86330","article-title":"Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)","volume":"12","author":"Leuthner","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ajem.2017.11.037_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2017.05.006","article-title":"Recently approved antibacterials for MRSA and other gram-positive pathogens: the shock of the new","author":"David","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"23","key":"10.1016\/j.ajem.2017.11.037_bb0045","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","article-title":"Once-weekly dalbavancin versus daily conventional therapy for skin infection","volume":"370","author":"Boucher","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ajem.2017.11.037_bb0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cid\/civ982","article-title":"A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection","volume":"62","author":"Dunne","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ajem.2017.11.037_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/21548331.2016.1230466","article-title":"Clinical pathway for moderate to severe acute bacterial skin and skin structure infections from a US perspective: a roundtable discussion","volume":"44","author":"Bosso","year":"2016","journal-title":"Hosp Pract"},{"issue":"2","key":"10.1016\/j.ajem.2017.11.037_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/QCO.0000000000000360","article-title":"What is new in the management of skin and soft tissue infections in 2016?","volume":"30","author":"Poulakou","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ajem.2017.11.037_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0213-005X(17)30034-4","article-title":"Potenciales indicaciones de dalbavancina en la pr\u00e1ctica cl\u00ednica","volume":"35","author":"Barber\u00e1n","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"90001","key":"10.1016\/j.ajem.2017.11.037_bb0070","doi-asserted-by":"crossref","first-page":"3i","DOI":"10.1093\/jac\/dkg466","article-title":"Managing skin and soft tissue infections: expert panel recommendations on key decision points","volume":"52","author":"Eron","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ajem.2017.11.037_bb0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajem.2016.10.034","article-title":"Newly approved antibiotics and antibiotics reserved for resistant infections: implications for emergency medicine","volume":"35","author":"Mazer-Amirshahi","year":"2017","journal-title":"Am J Emerg Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675717309476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675717309476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:38:12Z","timestamp":1760024292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675717309476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0735675717309476"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2017.11.037","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience with dalbavancin for cellulitis in the emergency department and emergency observation unit","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2017.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}